Cliniphar Ltd. (TYO:432A)
Japan flag Japan · Delayed Price · Currency is JPY
1,450.00
0.00 (0.00%)
Oct 7, 2025, 9:00 AM JST

Cliniphar Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Revenue
3,7003,7003,5853,526
Revenue Growth
-3.21%1.67%-
Gross Profit
643643665674
Operating Income
134134139161
Net Income
161161190-613
Earnings Per Share
161.00161.00190.00-613.00
EPS Growth
--15.26%--

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Cash & Investments
1,4401,4401,1421,193
Total Debt
1,0351,0351,4151,222
Net Cash (Debt)
405405-273-29
Net Cash Growth
----
Net Cash Per Share
405.00405.00-273.00-29.00

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Operating Cash Flow
279279--
Capital Expenditures
-10-10--
Free Cash Flow
269269--
Free Cash Flow Growth
----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024
Period EndingMar '26 Mar '26 Mar '25 Mar '24
Gross Margin
17.38%17.38%18.55%19.11%
Operating Margin
3.62%3.62%3.88%4.57%
Pretax Margin
3.97%3.97%5.52%-15.57%
Profit Margin
4.35%4.35%5.30%-17.39%
FCF Margin
7.27%7.27%--

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024
Period EndingAug '26 Mar '26 Mar '25 Mar '24
PE Ratio
9.019.01--
P/FCF Ratio
5.395.39--
PS Ratio
0.390.39--